Where does Adamis Pharmaceuticals Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Adamis Pharmaceuticals Corporation ranks #12,332 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Adamis Pharmaceuticals Corporation hold?

Adamis Pharmaceuticals Corporation holds 24 US utility patents granted between 2015 and 2023, spanning 15 technology areas.

What is Adamis Pharmaceuticals Corporation's Innovation Score?

Adamis Pharmaceuticals Corporation has an Innovation Score of 35.1 out of 100 (top 50% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Adamis Pharmaceuticals Corporation's patent grant rate increasing or decreasing?

Adamis Pharmaceuticals Corporation's recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Adamis Pharmaceuticals Corporation's patents?

Adamis Pharmaceuticals Corporation's patents average 14.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Adamis Pharmaceuticals Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Adamis Pharmaceuticals Corporation

Q: What technology areas does Adamis Pharmaceuticals Corporation focus on?

Adamis Pharmaceuticals Corporation's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 12 patents. Grants appear in 15 CPC subclasses total.

USPTO PatentsView assignee record - 24 granted patents across 15 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Adamis ranks #12,332 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 15 technology areas.

#12,332
of 49,997 US assignees by volume: Top 50%
by Innovation Score (35.1/100): 14.1
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12332 · US Corporation #12,332 · 24 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 24 grants
UPPER-Q #12,332/49,997
PHOTO-FINISH Acalvio
CPC-FOCUS A61M · 15 areas
INNOV-THIN 35.1/100
CLAIMS-RICH 14.1 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Acalvio Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Adamis Pharmaceuticals · this assignee

35
3D Lighting… · lowest

7

What this shows Adamis's Innovation Score is 35.1/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Adamis's grants concentrate

Adamis Pharmaceuticals Corporation is a focused PatentsView assignee: 15 CPC subclasses with 50% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2021 (6 grants) versus a trough of 1 in 2016. By volume, Adamis sits between Assia Chemical Industries Ltd. and Alpine Immune Sciences, Inc..

Adamis's three-year grant acceleration

Adamis Pharmaceuticals Corporation shows 3 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Assia Chemical In…

24
Avigilon Patent H…

24
Acalvio

24
Acxiom

24
Advance Research…

24
Airlite Plastics

24
Alakai

24
Alpine Immune Sci…

24
Adamis Pharmaceut… ◀

24

What this shows Adamis holds 24 patents at rank #12,346, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Adamis

By rank, the assignees closest to #12,346 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Adamis's primary technology class.

Adamis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 50% higher than 50% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Adamis Pharmaceuticals Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	12.5%
2016	1	4.2%
2017	2	8.3%
2018	4	16.7%
2019	5	20.8%
2021	6	25.0%
2022	1	4.2%
2023	2	8.3%

Which technologies does Adamis Pharmaceuticals Corporation patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 12

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

C01D - Compounds OF Alkali Metals, i.e. Lithium, Sodium, Potassium, Rubidium, Caesium, OR Francium 3

C08B - POLYSACCHARIDES; Derivatives Thereof 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

C08L - Compositions OF Macromolecular Compounds 3

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 3

B65H - Handling Thin OR Filamentary Material, e.g. Sheets, Webs, Cables 3

G06M - Counting MECHANISMS; Counting OF Objects NOT Otherwise Provided FOR 3

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 2

B05C - Apparatus FOR Applying Fluent Materials TO Surfaces, IN General 1

B65G - Transport OR Storage Devices, e.g. Conveyors FOR Loading OR Tipping, Shop Conveyor Systems OR Pneumatic Tube Conveyors 1

B02C - Crushing, Pulverising, OR Disintegrating IN GENERAL; Milling Grain 1

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

Top 15 of 15 technology areas

Where it ranks

Overall rank by patents

#12,332

of 49,997 tracked assignees

Innovation Score

35.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Adamis Pharmaceuticals Corporation's patent record in context - here's where to go next.

Adamis Pharmaceuticals Corporation's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 50% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #12,332 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Adamis Pharmaceuticals Corporation against Assia Chemical Industries Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.